Cited by 297Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and Signaling

Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex

Open access
González-Maeso, Javier, Yuen, Tony, Ebersole, Barbara J., Wurmbach, Elisa, Lira, Alena, Zhou, Mingming, Weisstaub, Noelia, Hen, Rene +2 more·2003·The Journal of Neuroscience

Abstract

Most neuropharmacological agents and many drugs of abuse modulate the activity of heptahelical G-protein-coupled receptors. Although the effects of these ligands result from changes in cellular signaling, their neurobehavioral activity may not correlate with results of in vitro signal transduction assays. 5-Hydroxytryptamine 2A receptor (5-HT2AR) partial agonists that have similar pharmacological profiles differ in the behavioral responses they elicit.In vitro studies suggest that different agonists acting at the same receptor may establish distinct patterns of signal transduction. Testing this hypothesis in the brain requires a global signal transduction assay that is applicable in vivo. To distinguish the cellular effects of the different 5-HT2AR agonists, we developed an assay for global signal transduction on the basis of high throughput quantification of rapidly modulated transcripts. Study of the responses to agonists in human embryonic kidney 293 cells stably expressing 5-HT2ARs demonstrated that each agonist elicits a distinct transcriptome fingerprint. We therefore studied behavioral and cortical signal transduction responses in wild-type and 5-HT2AR null-mutant mice. The hallucinogenic chemicals (±)-2,5-dimethoxy-4-iodoamphetamine (DOI) and lysergic acid diethylamide (LSD) stimulated a head-twitch behavioral response that was not observed with the nonhallucinogenic lisuride hydrogen maleate (LHM) and was absent in receptor null-mutant mice. We also found that DOI, LSD, and LHM each induced distinct transcriptome fingerprints in somatosensory cortex that were absent in 5-HT2AR null-mutants. Moreover, DOI and LSD showed similarities in the transcriptome fingerprints obtained that were not observed with the behaviorally inactive drug LHM. Our results demonstrate that chemicals acting at the 5-HT2AR induce specific cellular response patterns in vivo that are reflected in unique changes in the somatosensory cortex transcriptome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.23-26-08836.2003

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Findings from in vivo studies investigating acute effects of a single dose of 5-MeO-DMT, DMT, psilocybin, and LSD (37%) suggest altered cellular plasticity of structural and functional nature.

    “Findings from in vivo studies investigating acute effects of a single dose of 5-MeO-DMT, DMT, psilocybin, and LSD (37%) suggest altered cellular plasticity of structural and functional nature (54–60).”

    From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [56]

    The Results (page not available in our copy) report altered cortical gene expression one hour after a single LSD injection in mice, supporting an acute cellular response. The paper does not show structural plasticity, and it did not test 5-MeO-DMT, DMT, or psilocybin; the 37% figure is not established by this source. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • A single dose of LSD (0.20, 0.24, 0.5, 1.0 mg/kg i.p.) stimulated the mRNA expression of plasticity-promoting genes in the cortex of rats and mice, within 1-2 h after administration and in a time- and dose-dependent manner.

    “A single dose of LSD (0.20, 0.24, 0.5, 1.0 mg/kg i.p.) stimulated the mRNA expression of plasticity-promoting genes in the cortex of rats and mice, within 1–2 h after administration and in a time- and dose-dependent manner (56–59).”

    From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [56]

    The Results (page not available in our copy) report that LSD altered cortical transcripts in mice one hour after injection, including activation of egr-1, egr-2, and period-1; Figure 2 identifies an LSD dose of 0.24 mg/kg i.p. The paper does not establish this gene-expression finding in rats or at the other listed LSD doses. Its time-course and dose-response gene-expression experiments used DOI, not LSD. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 55 · Cited by 297

Authors
González-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., & Sealfon, S. C.
Affiliations
Columbia University (US)
Venue
The Journal of Neuroscience
Published
2003-10-01
Volume
23
Issue
26
Pages
8836-8843
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2171104921
Cited by
297
References
55
Citations by year
2026: 5 · 2025: 18 · 2024: 23 · 2023: 20 · 2022: 19 · 2021: 24 · 2020: 15 · 2019: 10 · 2018: 19 · 2017: 12 · 2016: 14 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 17
FWCI
6.04
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eusko Jaurlaritza
  • National Institutes of Health
  • National Institute on Drug Abuse (P01DA012923)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
5-HT2A receptor, hallucinogens, somatosensory cortex, 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, head-twitch response, G protein-coupled receptor signaling
MeSH terms
Animals, Behavior, Animal, Cell Line, Feasibility Studies, Hallucinogens, Humans, Kidney, Mice, Mutant Strains, Receptors, Serotonin, Somatosensory Cortex, Transcription, Genetic, Signal Transduction, Gene Expression, Mice, Knockout, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Receptor, Serotonin, 5-HT2A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review